apl. Prof. Dr. Robert Stöhr

Medizinische Fakultät

Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer (2020) Erber R, Hartmann A, Fasching P, Stöhr R, Beckmann M, Zentgraf M, Rübner M, et al. Conference contribution CCL2 expression in tumor cells and tumor-infiltrating immune cells shows divergent prognostic potential for bladder cancer patients depending on lymph node stage (2020) Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, Stöhr R, et al. Journal article Comparative genomic profiling of glandular bladder tumours (2020) Maurer A, Ortiz-Bruechle N, Guricova K, Rose M, Morsch R, Garczyk S, Stöhr R, et al. Journal article Pure large nested variant of urothelial carcinoma (Lnuc) is the prototype of an fgfr3 mutated aggressive urothelial carcinoma with luminal-papillary phenotype (2020) Weyerer V, Eckstein M, Compérat E, Juette H, Gaisa NT, Allory Y, Stöhr R, et al. Journal article Variant morphology and random chromosomal integration of BK polyomavirus in posttransplant urothelial carcinomas (2020) Bertz S, Enßer A, Stöhr R, Eckstein M, Apel H, Mayr D, Büttner-Herold M, et al. Journal article Immune Cell Gene Expression Signature is Associated with Improved Outcome in Muscle-Invasive Urothelial Bladder Cancer Patients Treated with Radical Cystectomy (2020) Eckstein M, Strissel P, Strick R, Weyerer V, Wirtz RM, Pfannstiel C, Wullweber A, et al. Conference contribution TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder (2020) Bertz S, Stöhr R, Gaisa NT, Wullich B, Hartmann A, Agaimy A Journal article FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020) van Rhijn BW, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, et al. Journal article Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations—is the term “thyroblastoma” more appropriate? (2020) Agaimy A, Witkowski L, Stöhr R, Cuenca JCC, González-Muller CA, Brütting A, Bährle M, et al. Journal article YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor (2020) Agaimy A, Stöhr R, Tögel L, Hartmann A, Cramer T Journal article